None
Quote | Almirall Sa Ord (OTCMKTS:LBTSF)
Last: | $9.51 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $9.51 |
High: | $0 |
Low: | $0 |
Volume: | 4 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Almirall Sa Ord (OTCMKTS:LBTSF)
2024-07-03 10:51:31 ET More on Absci Absci: 'AI' Tag Keeping Company Afloat While Searching For Right Formula Absci Corporation (ABSI) Q1 2024 Earnings Call Transcript Seeking Alpha’s Quant Rating on Absci Historical earnings data for Absci Fin...
Almirall’s sustainability strategy focuses on five pillars: Planet, People, Patients, Partners and Principles defining clear targets and measurements Among other commitments, Almirall aims to – by 2030 - reduce absolute direct greenhouse gas emissions by 50%, minimize the ge...
Message Board Posts | Almirall Sa Ord (OTCMKTS:LBTSF)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Almirall Sa Ord Company Name:
LBTSF Stock Symbol:
OTCMKTS Market:
Almirall’s sustainability strategy focuses on five pillars: Planet, People, Patients, Partners and Principles defining clear targets and measurements Among other commitments, Almirall aims to – by 2030 - reduce absolute direct greenhouse gas emissions by 50%, minimize the ge...
Almirall presented the interim Week 52 results of the POSITIVE clinical study at the IFPA Conference 2024, showing the benefits of the effective treatment with Ilumetri (tildrakizumab) in patients with moderate to severe psoriasis achieving improvement of physical symptoms and overall wellbeing. ...
Positive trajectory with Net Sales increase by 6.6% to a total of €247.4 MM, EBITDA increase of 1.4% YoY to a total of €52.5 MM driven by higher overall sales Performance driven by biologics as key growth engines, with Ilumetri ® showing 30% increase in sales vs Q1 ...